Skip to content

Author

J. Thanasai

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Prevalence of Hepatic and Splenic Melioidosis: A Systematic Review and Meta-Analysis

Background: Melioidosis is a potentially life-threatening infection caused by Burkholderia pseudomallei. Hepatic and splenic involvement are recognized manifestations of disseminated melioidosis; however, reported prevalence varies considerably across studies, and no quantitative synthesis has been available. This syst...

J. Thanasai, A. Chittamma, Supphachoke Khemla et al. · 0 citations
Review Open access Sep 2026

Clinical Spectrum and Organ Involvement in Pediatric Melioidosis: A Systematic Review and Meta-Analysis

Background: Pediatric melioidosis causes substantial morbidity and mortality in tropical regions, yet its clinical spectrum has not been comprehensively quantified. We conducted a systematic review and meta-analysis to characterize clinical manifestations, organ involvement, and mortality among children with melioidosi...

J. Thanasai, A. Chittamma, Supphachoke Khemla et al. · 0 citations
Review Open access Aug 2026

Point-of-Care Assessment of Kidney Function in Chronic Kidney Disease: Current Technologies and Future Perspectives

Established and emerging POCT approaches for kidney assessment in CKD are summarized, with emphasis on creatinine/eGFR and urine albumin-to-creatinine ratio (UACR), and analytical validity from workflow utility and patient-level clinical utility are distinguished.

Atthaphong Phongphithakchai, Kraiyasak Wongna, Ratana Netphakdee et al. · 0 citations
Review Open access Jul 2026

Alpha-Mangostin in Acute Kidney Injury: Molecular Mechanisms, Regulated Cell Death, and Translational Opportunities

Overall, current evidence suggests that AM has preliminary renoprotective potential in experimental AKI models, however, the limited number of available studies, predominance of cisplatin-induced nephrotoxicity models, insufficient pharmacokinetic and safety data, and absence of human clinical studies preclude conclusi...

Atthaphong Phongphithakchai, Nawanwat C. Pattaranggoon, Kraiyasak Wongna et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.